7 Oct 2026 · Case #032

IgA nephropathy

This page works the case through in full, answer included. If you would rather reason it out yourself: Play this case

Diagnosis

IgA nephropathy

First-line treatment

ACE inhibitor or ARB with blood pressure control

How the diagnosis is reached

Visible haematuria in a young adult is either urological or glomerular, and the microscopy settles it: dysmorphic red cells and casts can only form as blood crosses an inflamed glomerulus, so stones, infection and bladder pathology fall away. Which glomerulonephritis is then answered by the timing. IgA nephropathy produces haematuria synpharyngitically, within one to three days of a mucosal infection and while the sore throat is still present, because the circulating galactose-deficient IgA1 complexes are already there and deposit in the mesangium as soon as production surges. Post-streptococcal glomerulonephritis, its closest mimic, runs the other way: it needs one to three weeks after a pharyngitis for immune complexes to form, so a throat still sore when the urine turns red argues strongly against it. Complement seals the split: post-streptococcal disease consumes complement and drives C3 down, whereas C3 and C4 are normal in IgA nephropathy, as they are here. Negative ANCA and anti-GBM exclude the small-vessel vasculitides and Goodpasture disease; a negative ANA with normal complement excludes lupus nephritis, which would stain as a full house with IgG and C1q rather than IgA-dominant. The self-limiting episode two years ago fits the characteristic recurrent, infection-triggered course, and the biopsy is definitive. Although this episode looks benign, a quarter to a third of patients reach end-stage kidney disease over two to three decades, and that is why the treatment is not immunosuppression but hard supportive control of the two drivers, both abnormal here. An ACE inhibitor or angiotensin receptor blocker is titrated to the maximum tolerated dose against a systolic target near 120, well under his 142, with an SGLT2 inhibitor for proteinuria that persists. His albumin:creatinine ratio of 148 mg/mmol is roughly 1.5 g a day, above the level at which corticosteroids enter the conversation, but they wait until several months of optimised supportive therapy have been tried, because the benefit is modest and the infection risk is not.

Key clinical clues

The case in full

1

Presenting complaint

Patient history

A 24-year-old man attends after two days of passing visibly red-brown urine. It is painless (no burning, no urgency and no loin pain) and the discolouration is present throughout the stream rather than only at the beginning or the end.

2

History and background

Patient history

He has had a sore throat, mild fever and malaise for three days, and the urine changed colour on the second day of it. A similar episode two years ago, during a chest infection, settled by itself. He takes no medication, and there is no family history of kidney disease or deafness.

3

Examination and observations

Vital signs

He looks well. There is no rash, no joint swelling, no oral ulceration and no haemoptysis. His chest is clear and there is no peripheral oedema.

Measurements
ParameterValue
Blood pressure142/88 mmHgRef <130/80
Heart rate76 bpmRef 60–100
Temperature37.4 °CRef 36.1–37.5
SpO₂ (room air)99 %Ref 95–100
4

Urinalysis and renal function

Laboratory results

A fresh urine sample is examined under the microscope and bloods are sent.

Measurements
ParameterValue
Urine dipstick, blood3+Ref Negative
Urine dipstick, protein2+Ref Negative
Urine microscopyDysmorphic red cells, red cell castsRef No casts
Urine albumin:creatinine ratio148 mg/mmolRef <3
Creatinine124 µmol/LRef 60–110
eGFR68 mL/min/1.73m²Ref >90
Albumin39 g/LRef 35–50
5

Immunology screen

Laboratory results

A serological panel is sent to narrow the cause of a glomerular bleed.

Measurements
ParameterValue
Complement C31.18 g/LRef 0.75–1.65
Complement C40.28 g/LRef 0.14–0.54
Anti-streptolysin O titre<200 IU/mLRef <200
ANANegativeRef Negative
ANCANegativeRef Negative
Anti-GBM antibodyNegativeRef Negative
Serum IgA4.1 g/LRef 0.8–3.0
6

Renal biopsy

Pathology

Light microscopy of a renal biopsy shows mesangial hypercellularity with matrix expansion; capillary walls are normal and no crescents are seen. Immunofluorescence shows dominant granular mesangial IgA with weaker C3, and no IgG or C1q.